JP2007532605A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007532605A5 JP2007532605A5 JP2007507767A JP2007507767A JP2007532605A5 JP 2007532605 A5 JP2007532605 A5 JP 2007532605A5 JP 2007507767 A JP2007507767 A JP 2007507767A JP 2007507767 A JP2007507767 A JP 2007507767A JP 2007532605 A5 JP2007532605 A5 JP 2007532605A5
- Authority
- JP
- Japan
- Prior art keywords
- epa
- dha
- content
- ethyl ester
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04101578 | 2004-04-16 | ||
| PCT/EP2005/004031 WO2005110393A1 (en) | 2004-04-16 | 2005-04-15 | Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007532605A JP2007532605A (ja) | 2007-11-15 |
| JP2007532605A5 true JP2007532605A5 (https=) | 2012-01-26 |
Family
ID=34928968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007507767A Pending JP2007532605A (ja) | 2004-04-16 | 2005-04-15 | 冠性心疾患または冠状動脈疾患を持つ患者の鬱病の予防および／または治療における必須脂肪酸 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1765319A1 (https=) |
| JP (1) | JP2007532605A (https=) |
| CN (1) | CN1942180A (https=) |
| AU (1) | AU2005244483B2 (https=) |
| BR (1) | BRPI0509878A (https=) |
| CA (1) | CA2504280A1 (https=) |
| IL (1) | IL178300A0 (https=) |
| MX (1) | MX291518B (https=) |
| RU (1) | RU2387448C2 (https=) |
| UA (1) | UA94693C2 (https=) |
| WO (1) | WO2005110393A1 (https=) |
| ZA (1) | ZA200607794B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2421909A (en) * | 2004-12-23 | 2006-07-12 | Laxdale Ltd | Pharmaceutical compositions comprising EPA and methods of use |
| ITMI20100961A1 (it) * | 2010-05-27 | 2011-11-28 | Erredue Spa | Miscele ricche in esteri di acidi grassi omega-3, loro composizioni e loro processo di preparazione |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998048788A1 (en) * | 1997-04-29 | 1998-11-05 | Scotia Holdings Plc | Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants |
| IT1308613B1 (it) * | 1999-02-17 | 2002-01-09 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella prevenzione di eventi cardiovascolari. |
| GB9916536D0 (en) * | 1999-07-14 | 1999-09-15 | Scarista Limited | Nutritional or pharmaceutical compositions |
| ATE291910T1 (de) * | 2001-05-30 | 2005-04-15 | Laxdale Ltd | Verwendung von coenzym q (ubiquinone) und eikosapentaensäure (epa) für die behandlung von non-hodgkin's lymphoma und psychiatrischen oder neurologischen erkrankungen |
-
2005
- 2005-04-15 ZA ZA200607794A patent/ZA200607794B/en unknown
- 2005-04-15 JP JP2007507767A patent/JP2007532605A/ja active Pending
- 2005-04-15 BR BRPI0509878-5A patent/BRPI0509878A/pt not_active IP Right Cessation
- 2005-04-15 UA UAA200611798A patent/UA94693C2/ru unknown
- 2005-04-15 CA CA002504280A patent/CA2504280A1/en not_active Abandoned
- 2005-04-15 WO PCT/EP2005/004031 patent/WO2005110393A1/en not_active Ceased
- 2005-04-15 MX MXPA06011940 patent/MX291518B/es active IP Right Grant
- 2005-04-15 RU RU2006140277/14A patent/RU2387448C2/ru not_active IP Right Cessation
- 2005-04-15 AU AU2005244483A patent/AU2005244483B2/en not_active Ceased
- 2005-04-15 EP EP05779398A patent/EP1765319A1/en not_active Withdrawn
- 2005-04-15 CN CNA2005800114285A patent/CN1942180A/zh active Pending
-
2006
- 2006-09-26 IL IL178300A patent/IL178300A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5441287B2 (ja) | 心血管事象を予防するための必須脂肪酸 | |
| MXPA05009432A (es) | Uso de acidos grasos omega-3 en el tratamiento de pacientes diabeticos. | |
| JP5827784B2 (ja) | ビタミンｋ２を含む医薬及び栄養補助製品 | |
| EP1310249B1 (en) | Use of polyunsatured fatty acids for the primary prevention of major cardiovascular events | |
| JP2004517148A (ja) | 心機能不全および心不全の治療における必須ｎ−３脂肪酸 | |
| CA2905671A1 (en) | Omega-3 pentaenoic acid compositions and methods of use | |
| US20040235948A1 (en) | Treatment of diabetic patients with omega-3-fatty acids | |
| US8114906B2 (en) | Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease | |
| CN102149376B (zh) | 症状性心力衰竭的长期治疗 | |
| JP2007532605A5 (https=) | ||
| JP2007532605A (ja) | 冠性心疾患または冠状動脈疾患を持つ患者の鬱病の予防および／または治療における必須脂肪酸 | |
| JP2014505729A (ja) | コレステロールの低減および心血管事象の低減のための、コレステロール吸収阻害剤（アゼチジノン）およびω３脂肪酸（ＥＰＡ、ＤＨＡ、ＤＰＡ） | |
| US20250255842A1 (en) | Specialized pro-resolving lipid mediators for treating long covid-19 | |
| HK1099700A (en) | Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease | |
| GB2620543A (en) | Composition for use | |
| WO1993009773A1 (fr) | Composition servant a prevenir ou a traiter la dysmenorrhee et aliment ayant une fonction de prevention de la dysmenorrhee |